{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:08:24Z","timestamp":1783534104939,"version":"3.55.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.rmr.2023.02.007","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T07:56:21Z","timestamp":1681458981000},"page":"391-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["La maladie de Rendu-Osler (t\u00e9langiectasie h\u00e9morragique h\u00e9r\u00e9ditaire)"],"prefix":"10.1016","volume":"40","author":[{"given":"A.","family":"Parrot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bachmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Eyries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alamowitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ederhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Epaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dupuis-Girod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2023.02.007_bib0495","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.ejmg.2021.104370","article-title":"The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care","volume":"65","author":"Shovlin","year":"2022","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.rmr.2023.02.007_bib0500","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13023-018-0982-4","article-title":"Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Buscarini","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0505","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2023.02.007_bib0510","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13023-019-1281-4","article-title":"Future treatments for hereditary hemorrhagic telangiectasia","volume":"15","author":"Robert","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0515","first-page":"9","article-title":"\u00c9tude \u00e9pid\u00e9miologique de la maladie de Rendu-Osler en France: r\u00e9partition g\u00e9ographique et pr\u00e9valence","volume":"44","author":"Bideau","year":"1989","journal-title":"Popul Fr Ed"},{"key":"10.1016\/j.rmr.2023.02.007_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31802f8da1","article-title":"Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126\u00a0patients","volume":"86","author":"Cottin","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2023.02.007_bib0525","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.0000000000001538","article-title":"Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study","volume":"84","author":"Donaldson","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2023.02.007_bib0530","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13023-016-0427-x","article-title":"Life expextancy of parents with hereditary haemorrhagic telangiectasia","volume":"11","author":"de Gussem","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0535","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-020-01579-2","article-title":"Predictors of mortality in patients with hereditary hemorrhagic telangiectasia","volume":"16","author":"Thompson","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0540","doi-asserted-by":"crossref","first-page":"E3581","DOI":"10.3390\/jcm9113581","article-title":"Hereditary Hemorrhagic Telangiectasia (HHT) and survival: the importance of systematic screening and treatment in HHT centers of excellence","volume":"9","author":"de Gussem","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0545","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1513\/AnnalsATS.201603-200OC","article-title":"High rates of bleeding complications among hospitalized patients with hereditary hemorrhagic telangiectasia in the United States","volume":"13","author":"Brinjikji","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmr.2023.02.007_bib0550","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajmg.a.62522","article-title":"Clinical manifestations of patients with GDF2\u00a0mutations associated with hereditary hemorrhagic telangiectasia type 5","volume":"188","author":"Farhan","year":"2022","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.rmr.2023.02.007_bib0555","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ajmg.a.62584","article-title":"Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations","volume":"188","author":"Balachandar","year":"2022","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.rmr.2023.02.007_bib0560","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.3390\/jcm11175245","article-title":"Hereditary hemorrhagic telangiectasia: genetics, pathophysiology, diagnosis, and management","volume":"11","author":"Viteri-No\u00ebl","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0565","first-page":"3487","article-title":"Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia","volume":"119","author":"Park","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmr.2023.02.007_bib0570","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2021.09.003","article-title":"Translational medicine in hereditary hemorrhagic telangiectasia","volume":"95","author":"Riera-Mestre","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0575","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","article-title":"Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in Bi-allelic loss of ENG or ACVRL1","volume":"105","author":"Snellings","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rmr.2023.02.007_bib0580","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.2020008739","article-title":"Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care","volume":"137","author":"Al-Samkari","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rmr.2023.02.007_bib0585","doi-asserted-by":"crossref","first-page":"E1262","DOI":"10.3390\/jcm9051262","article-title":"Efficacy and safety of a 0.1\u00a0% tacrolimus nasal ointment as a treatment for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled, multicenter trial","volume":"9","author":"Dupuis-Girod","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0590","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13023-022-02426-2","article-title":"Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT","volume":"17","author":"Le","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0595","first-page":"315","article-title":"The lung in hereditary hemorrhagic telangiectasia","volume":"94","author":"Dupuis-Girod","year":"2017","journal-title":"Respir Int Rev Thorac Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0600","first-page":"361","article-title":"Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease)","volume":"74","author":"Cottin","year":"2007","journal-title":"Respir Int Rev Thorac Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0605","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09031936.00049008","article-title":"Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study","volume":"33","author":"van Gent","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.02.007_bib0610","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1378\/chest.09-1849","article-title":"Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study","volume":"138","author":"van Gent","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2023.02.007_bib0615","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1051-0443(96)70851-5","article-title":"Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy","volume":"7","author":"White","year":"1996","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"10.1016\/j.rmr.2023.02.007_bib0620","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2214\/AJR.19.22012","article-title":"CT angiography findings of pulmonary arteriovenous malformations in children and young adults with hereditary hemorrhagic telangiectasia","volume":"214","author":"Shin","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0625","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00330-017-5047-x","article-title":"Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: correlations between computed tomography findings and cerebral complications","volume":"28","author":"Etievant","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0630","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clineuro.2011.10.036","article-title":"Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation","volume":"114","author":"Mathis","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.rmr.2023.02.007_bib0635","doi-asserted-by":"crossref","first-page":"e88812","DOI":"10.1371\/journal.pone.0088812","article-title":"Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets","volume":"9","author":"Shovlin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.rmr.2023.02.007_bib0640","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1161\/STROKEAHA.120.032073","article-title":"Ischemic stroke in patients with pulmonary arteriovenous fistulas","volume":"52","author":"Topiwala","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.rmr.2023.02.007_bib0645","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.2007.087452","article-title":"Primary determinants of ischaemic stroke\/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia","volume":"63","author":"Shovlin","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2023.02.007_bib0650","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000478734","article-title":"Pulmonary arteriovenous malformations are associated with silent brain infarcts in hereditary hemorrhagic telangiectasia patients","volume":"44","author":"Brinjikji","year":"2017","journal-title":"Cerebrovasc Dis Basel Switz"},{"key":"10.1016\/j.rmr.2023.02.007_bib0655","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1161\/STROKEAHA.120.032073","article-title":"Ischemic stroke in patients with pulmonary arteriovenous fistulas","volume":"52","author":"Topiwala","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.rmr.2023.02.007_bib0660","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/thoraxjnl-2017-210764","article-title":"British Thoracic Society clinical statement on pulmonary arteriovenous malformations","volume":"72","author":"Shovlin","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2023.02.007_bib0665","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1378\/chest.128.4.2485","article-title":"A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine","volume":"128","author":"Post","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2023.02.007_bib0670","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.3390\/jcm10204714","article-title":"Incidence of spontaneous pulmonary AVM rupture in HHT patients","volume":"10","author":"Fish","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0675","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/AOG.0000000000000120","article-title":"Outcomes of pregnancy in women with hereditary hemorrhagic telangiectasia","volume":"123","author":"de Gussem","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0680","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1471-0528.2008.01786.x","article-title":"Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for obstetric services","volume":"115","author":"Shovlin","year":"2008","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0685","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0690","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09031936.00049008","article-title":"Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study","volume":"33","author":"van Gent","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.02.007_bib0695","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1378\/chest.13-0716","article-title":"Role of transthoracic contrast echocardiography in the clinical diagnosis of hereditary hemorrhagic telangiectasia","volume":"144","author":"Velthuis","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2023.02.007_bib0700","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1378\/chest.06-2356","article-title":"Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT","volume":"132","author":"Zukotynski","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2023.02.007_bib0705","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1183\/09031936.00133713","article-title":"Predicting the size of pulmonary arteriovenous malformations on chest computed tomography: a role for transthoracic contrast echocardiography","volume":"44","author":"Velthuis","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.02.007_bib0710","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/1055-9965.EPI-13-0665","article-title":"Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia","volume":"23","author":"Duarte","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.rmr.2023.02.007_bib0715","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rmed.2018.12.013","article-title":"Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000\u00a0to 2014","volume":"147","author":"Harder","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0720","doi-asserted-by":"crossref","first-page":"e0184227","DOI":"10.1371\/journal.pone.0184227","article-title":"Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability","volume":"12","author":"Revuz","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.rmr.2023.02.007_bib0725","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/gim.2013.62","article-title":"Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes","volume":"16","author":"Canzonieri","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0730","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.rmr.2023.02.007_bib0735","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00330-011-2243-y","article-title":"Hepatic and pancreatic involvement in hereditary hemorrhagic telangiectasia: quantitative and qualitative evaluation with 64-section CT in asymptomatic adult patients","volume":"22","author":"Barral","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0740","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s41436-020-0826-1","article-title":"Disease expression in juvenile polyposis syndrome: a retrospective survey on a cohort of 221\u00a0European patients and comparison with a literature-derived cohort of 473\u00a0SMAD4\/BMPR1A pathogenic variant carriers","volume":"22","author":"Blatter","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0745","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1053\/j.gastro.2022.02.021","article-title":"Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the US multi-society task force on colorectal cancer","volume":"162","author":"Boland","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rmr.2023.02.007_bib0750","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2004-813549","article-title":"Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia\u00a0\u2013\u00a0results of extensive screening","volume":"25","author":"Buscarini","year":"2004","journal-title":"Ultraschall Med Stuttg Ger"},{"key":"10.1016\/j.rmr.2023.02.007_bib0755","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00261-003-0101-3","article-title":"Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings","volume":"29","author":"Memeo","year":"2004","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.rmr.2023.02.007_bib0760","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s10620-011-1585-2","article-title":"Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia","volume":"56","author":"Buscarini","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rmr.2023.02.007_bib0765","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1478-3231.2006.01340.x","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations","volume":"26","author":"Buscarini","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.rmr.2023.02.007_bib0770","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.2169\/internalmedicine.1056-18","article-title":"Hepatocellular carcinoma in a patient with hereditary hemorrhagic telangiectasia","volume":"57","author":"Morii","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0775","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1007\/s00261-018-1671-4","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia","volume":"43","author":"Buscarini","year":"2018","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.rmr.2023.02.007_bib0780","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13023-017-0632-2","article-title":"Central nervous system manganese induced lesions and clinical consequences in patients with hereditary hemorrhagic telangiectasia","volume":"12","author":"Serra","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0785","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3171\/2016.7.JNS16847","article-title":"Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis","volume":"127","author":"Brinjikji","year":"2017","journal-title":"J Neurosurg"},{"key":"10.1016\/j.rmr.2023.02.007_bib0790","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13023-020-01386-9","article-title":"European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)","volume":"15","author":"Eker","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0795","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/1591019915623560","article-title":"Spinal arteriovenous fistulae in patients with hereditary hemorrhagic telangiectasia: A case report and systematic review of the literature","volume":"22","author":"Brinjikji","year":"2016","journal-title":"Interv Neuroradiol J Peritherapeutic"},{"key":"10.1016\/j.rmr.2023.02.007_bib0800","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.rmr.2023.02.007_bib0805","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41436-020-0775-8","article-title":"Cura\u00e7ao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1\u00a0and HHT2)","volume":"22","author":"McDonald","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0810","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jmedgenet-2019-106794","article-title":"Low grade mosaicism in hereditary haemorrhagic telangiectasia identified by bidirectional whole genome sequencing reads through the 100,000\u00a0Genomes Project clinical diagnostic pipeline","volume":"57","author":"Clarke","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.rmr.2023.02.007_bib0815","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jmedgenet-2019-106792","article-title":"RASA1\u00a0phenotype overlaps with hereditary haemorrhagic telangiectasia: two case reports","volume":"58","author":"El Hajjam","year":"2021","journal-title":"J Med Genet"},{"key":"10.1016\/j.rmr.2023.02.007_bib0820","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jpeds.2013.02.021","article-title":"Prevalence of pulmonary arteriovenous malformations in children versus adults with hereditary hemorrhagic telangiectasia","volume":"163","author":"Latino","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2023.02.007_bib0825","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ppul.23649","article-title":"Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: results from two pediatric centers","volume":"52","author":"Soysal","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0830","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018786696","article-title":"Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study","volume":"8","author":"Mowers","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.rmr.2023.02.007_bib0835","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pediatrneurol.2020.05.008","article-title":"Cerebrovascular malformations in a pediatric hereditary hemorrhagic telangiectasia cohort","volume":"110","author":"Beslow","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0840","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13023-019-1286-z","article-title":"Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature","volume":"15","author":"Dupuis","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0845","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/1471-0528.17303","article-title":"Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: a retrospective study","volume":"130","author":"Delagrange","year":"2022","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0850","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.13606","article-title":"How to manage patients with hereditary haemorrhagic telangiectasia","volume":"171","author":"Geisthoff","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0855","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3390\/jcm11185280","article-title":"Efficacy and safety of tacrolimus as treatment for bleeding caused by hereditary hemorrhagic telangiectasia: an open-label, pilot study","volume":"11","author":"Hessels","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0860","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2017.11.013","article-title":"Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding","volume":"93","author":"Iyer","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rmr.2023.02.007_bib0865","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jvir.2021.01.271","article-title":"Comparison of feeding-artery-only versus nidus-plus-feeding-artery embolization of pulmonary arteriovenous malformations","volume":"32","author":"Roberts","year":"2021","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"10.1016\/j.rmr.2023.02.007_bib0870","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2214\/AJR.17.19200","article-title":"Pulmonary arteriovenous malformations: safety and efficacy of microvascular plugs","volume":"211","author":"Mahdjoub","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0875","first-page":"CD008017","article-title":"Embolisation for pulmonary arteriovenous malformation","volume":"1","author":"Hsu","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2023.02.007_bib0880","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5152\/dir.2015.15262","article-title":"Persistence of pulmonary arteriovenous malformations after successful embolotherapy with Amplatzer vascular plug: long-term results","volume":"22","author":"Abdel-Aal","year":"2016","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0885","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00330-015-4090-8","article-title":"Vein diameter on unenhanced multidetector CT predicts reperfusion of pulmonary arteriovenous malformation after embolotherapy","volume":"26","author":"Gamond\u00e8s","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0890","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s00270-016-1357-7","article-title":"Amplatzer vascular plugs versus coils for embolization of pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia","volume":"39","author":"Tau","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0895","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jvir.2019.02.025","article-title":"Retrospective comparison of pulmonary arteriovenous malformation embolization with the polytetrafluoroethylene-covered nitinol microvascular plug, AMPLATZER plug, and coils in patients with hereditary hemorrhagic telangiectasia","volume":"30","author":"Ratnani","year":"2019","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"10.1016\/j.rmr.2023.02.007_bib0900","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jtcvs.2017.04.069","article-title":"Surgery versus percutaneous transcatheter embolization for pulmonary arteriovenous malformation: analysis of a national inpatient database in Japan","volume":"154","author":"Nagano","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.rmr.2023.02.007_bib0905","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.otohns.2006.12.019","article-title":"Health-related quality of life in hereditary hemorrhagic telangiectasia","volume":"136","author":"Geisthoff","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.rmr.2023.02.007_bib0910","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.transproceed.2021.11.010","article-title":"Resolution of precapillary pulmonary hypertension after liver transplantation for hereditary hemorrhagic telangiectasia: systematic review and case report","volume":"54","author":"Perrodin","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.rmr.2023.02.007_bib0915","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/liv.13210","article-title":"Hereditary hemorrhagic telangiectasia: to transplant or not to transplant?","volume":"36","author":"Dupuis-Girod","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.rmr.2023.02.007_bib0920","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jth.12654","article-title":"Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease","volume":"12","author":"Gaillard","year":"2014","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.rmr.2023.02.007_bib0925","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.thromres.2014.06.012","article-title":"Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid\u00a0\u2013\u00a0a double-blind placebo-controlled cross-over phase IIIB study","volume":"134","author":"Geisthoff","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rmr.2023.02.007_bib0930","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.rmr.2023.02.007_bib0935","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.2016.11387","article-title":"Effect of bevacizumab nasal spray on epistaxis duration in hereditary hemorrhagic telangectasia: a randomized clinical trial","volume":"316","author":"Dupuis-Girod","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2023.02.007_bib0940","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/alr.22961","article-title":"Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization","volume":"12","author":"Khanwalkar","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0945","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/0003489419826139","article-title":"Bevacizumab as treatment for epistaxis in hereditary hemorrhagic telangiectasia: a literature review","volume":"128","author":"Kini","year":"2019","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0950","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nm.2131","article-title":"Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia","volume":"16","author":"Lebrin","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0955","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2352-3026(15)00195-7","article-title":"Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2\u00a0study","volume":"2","author":"Invernizzi","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rmr.2023.02.007_bib0960","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10456-018-9646-1","article-title":"Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia","volume":"22","author":"Faughnan","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0965","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10456-021-09807-4","article-title":"Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia","volume":"25","author":"Parambil","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0970","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13023-019-1179-1","article-title":"Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Shovlin","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2023.02.007_bib0975","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMc1213554","article-title":"Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia","volume":"368","author":"Devlin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2023.02.007_bib0490","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.carrev.2022.04.005","article-title":"Left atrial appendage occlusion in hereditary haemorrhagic telangiectasia patients (Rendu-Osler Syndrome) with non-valvular atrial fibrillation: prevention of cardioembolic events while avoiding the long-term risks of oral anticoagulation","volume":"43","author":"Cepas-Guillen","year":"2022","journal-title":"Cardiovasc Revascularization Med Mol Interv"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842523001365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842523001365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:25:00Z","timestamp":1760106300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842523001365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0761842523001365"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2023.02.007","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La maladie de Rendu-Osler (t\u00e9langiectasie h\u00e9morragique h\u00e9r\u00e9ditaire)","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2023.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}